LLMs in Pharmacoepidemiology — Applications, Capabilities, and Real-World Research
OVERVIEWA primer published for pharmacoepidemiologists introduces large language models (LLMs) as a subtype of generative AI capable of generating and interpreting text, with some models able to process multimodal content including images, audio, and video. LLMs can be deployed as autonomous or semi-autonomous agents to perform complex user-directed tasks beyond simple query-response interactions. Key natural language processing functions relevant to pharmacoepidemiology include summarization, translation, and information extraction from unstructured clinical text. These capabilities position LLMs to enhance and scale pharmacoepidemiological and real-world evidence research — for example, by extracting drug exposure data from clinical notes, identifying adverse event signals in free-text records, or synthesizing literature at scale. The article serves as a foundational reference for pharmacoepidemiologists unfamiliar with AI terminology, distinguishing LLMs from other machine learning approaches and explaining concepts such as multimodal processing and agentic deployment. Authors note that while the potential for LLMs to accelerate real-world research is substantial, appropriate domain expertise and validation frameworks remain essential before routine research integration. The piece reflects growing interest in AI as a methodological tool within epidemiological and regulatory science disciplines. ---
Subscribe to read full wiki analysis
Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.
View Plans & SubscribeNew users get a 7-day trial — no credit card required.